Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,06 USD | +2,91% | +0,95% | +0,95% |
01/04 | Quince Therapeutics, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
26/03 | Transcript : Quince Therapeutics, Inc. - Special Call |
Vakgebied
Aantal werknemers: 32
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dirk Thye
CEO | Chief Executive Officer | 54 | 19-05-22 |
Brendan Hannah
DFI | Director of Finance/CFO | 39 | 01-05-22 |
Charles Ryan
PSD | President | 60 | 01-09-23 |
Maureen M. Roden
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-22 |
Stacy Roughan
IRC | Investor Relations Contact | - | - |
Gary Ward
PRN | Corporate Officer/Principal | - | 01-08-22 |
Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Una Ryan
BRD | Director/Board Member | 82 | 01-03-18 |
Luca Benatti
BRD | Director/Board Member | 63 | 23-10-23 |
Dirk Thye
CEO | Chief Executive Officer | 54 | 19-05-22 |
David Lamond
CHM | Chairman | 49 | 01-12-15 |
Rajiv Patni
BRD | Director/Board Member | 55 | 15/02 |
Director/Board Member | 56 | 01-03-19 | |
Director/Board Member | 61 | 01-12-15 | |
June Bray
BRD | Director/Board Member | 70 | 09-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 43 215 233 | 35 841 506 ( 82,94 %) | 0 | 82,94 % |
Bedrijfsgegevens
Quince Therapeutics, Inc.
611 Gateway Boulevard Suite 273
94080, South San Francisco
+
http://quincetx.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,95% | 45,81 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers QNCX
- Onderneming Quince Therapeutics, Inc.